Radiopharm Theranostics Limited (ASX:RAD)
Australia flag Australia · Delayed Price · Currency is AUD
0.0280
+0.0010 (3.70%)
Aug 29, 2025, 3:37 PM AEST

Radiopharm Theranostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
6652173638-
Market Cap Growth
197.41%197.41%-50.90%-7.01%--
Enterprise Value
351416136-
Last Close Price
0.030.020.040.100.14-
PS Ratio
4.893.848.935.74--
PB Ratio
1.541.210.640.780.61-
P/TBV Ratio
----5.56-
EV/Sales Ratio
2.601.068.022.04--
Debt / Equity Ratio
------0.47
Asset Turnover
0.170.170.030.08--
Quick Ratio
2.652.651.111.223.430.21
Current Ratio
2.672.671.301.233.460.21
Return on Equity (ROE)
-109.20%-109.20%-131.49%-63.78%-96.82%-
Return on Assets (ROA)
-26.89%-26.89%-30.04%-22.57%-29.86%-
Return on Capital (ROIC)
-60.70%-60.70%-60.55%-32.93%-39.60%-
Earnings Yield
-55.43%-70.54%-274.09%-97.15%-79.40%-
FCF Yield
--70.43%-131.34%-65.25%-25.86%-
Buyback Yield / Dilution
-439.62%-439.62%-26.36%-68.74%--
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.